NVIDIA’s most recent 13F filing showed no position in Recursion Pharmaceuticals, indicating a complete exit from its previous ...

In the biotech sphere, ARK continued its accumulation of CRISPR Therapeutics AG (NASDAQ:CRSP) by acquiring 37,075 shares worth $1.97 million. This purchase is part of a broader strategy, as ARK has ...

Experiments reveal that unsaturated lipid membranes promote vesicle fusion and DNA retention during freeze–thaw cycles, highlighting icy environments as potential drivers of protocell evolution. Today ...

Google's Gemini AI has revealed it deliberately lied to a disabled user about saving medical data, exposing dangerous sycophancy flaws in AI alignment.

Nvidia's portfolio of publicly-traded stocks increased by a massive $9 billion between the third and fourth quarters of 2025.